bioRxiv Science⌕ Search

Biology subjects

Murai, H.

Publications and source records attributed to Murai, H..

2 recordsLinked to original sources

Radiocesium Uptake in Two Fungal Bed-cultivated Edible Mushroom Species in Forests in Fukushima, Japan

In Japan, mushrooms have long been valued as food resources, but the Fukushima nuclear accident disrupted production and shipment due to radiocesium contamination. Limited knowledge has particularly hindered outdoor fungal bed cultivation. To address this, we conducted cultivation experiments with Lyophyllum decastes and Lepista nuda across 14 broad-leaved deciduous forest sites in Fukushima Prefecture. Air dose rates at 1 m height ranged from 0.04 to 0.89 {micro}Sv/h. Radiocesium concentrations (combined 137Cs and 134Cs, expressed as Bq/kg at 90% water content) in fruit bodies were 0.4-12 (mean 2.3) for Ly. decastes and 0.2-43 (mean 8.1) for Le. nuda. Both species remained below Japans food safety threshold of 100 Bq/kg, indicating that safe cultivation is feasible across broad areas. Uptake patterns differed: concentrations in Ly. decastes correlated with contamination in litter and multiple soil layers, whereas in Le. nuda it correlated only with litter contamination. These findings suggest that clean soil fills for Ly. decastes and clean litter covers for Le. nuda could serve as mitigation strategies tailored to each species. Aggregated transfer factors (2.76 x 10-5 m2/kg for Ly. decastes and 6.60 x 10-5 m2/kg for Le. nuda) were lower than those reported for wild mushrooms. Overall, this study provides new insights into reducing radiocesium assimilation by cultivated mushrooms and supports the revival of outdoor fungal bed cultivation in contaminated landscapes.

ecology↗

PLZF is a new substrate of CRBN with thalidomide and 5-hydroxythalidomide

Thalidomide induces cereblon (CRBN)-dependent degradation of proteins. Human cytochrome P450s are thought to provide two monohydroxylated metabolites from thalidomide, and the metabolites are also considered to be involved in thalidomide effects. However, it remains unclear. We report that human PLZF/ZBTB16 is a target protein of CRBN with thalidomide and its derivatives, and that 5-hydroxythalidomide has high potential for degrading PLZF. Using a human transcription factor protein array produced by a wheat cell-free protein synthesis system, PLZF was found to bind to CRBN with thalidomide. PLZF is degraded by the CRL4CRBN complex with thalidomide and its derivatives. Mutagenesis analysis revealed that both 1st and 3rd zinc finger domains conserved in vertebrates are recognized for thalidomide-dependent binding and degradation by CRBN. In chicken limbs, knockdown of Plzf induced skeletal abnormalities, and Plzf was degraded after thalidomide or 5-hydroxythalidomide treatment. Our findings suggest that PLZF is a pivotal substrate involving thalidomide-induced teratogenesis.

pharmacology and toxicology↗